18F-FDG PET/CT in suspected recurrences of epithelial malignant pleural mesothelioma in asbestos-fibers-exposed patients (comparison to standard diagnostic follow-up).
This retrospective study evaluated the role of 18-fluorine-labeled 2-deoxy-2-fluoro-D-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) in patients with previous occupational or environmental exposure to asbestos, with histopathological diagnosis of epithelial malignant pleural mesothelioma and suspected recurrences, comparing the data from 18F-FDG PET/CT and computed tomography with contrast enhancement (CECT). 18F-FDG PET/CT has greater sensitivity than CECT in identifying local extent, lymph nodes, and metastasis. 18F-FDG PET/CT whole-body explorations are useful to monitor the follow-up and evaluate the metabolic response to chemo- and radiotherapy, modifying the scheduled treatment plan.
['Niccoli-Asabella|Artor|A|', 'Notaristefano|Antonio|A|', 'Rubini|Domenico|D|', 'Altini|Corinna|C|', 'Ferrari|Cristina|C|', 'Merenda|Nunzio|N|', 'Fanelli|Margherita|M|', 'Rubini|Giuseppe|G|']
D000368:Aged D000369:Aged, 80 and over D001194:Asbestos D004781:Environmental Exposure D005260:Female D019788:Fluorodeoxyglucose F18 D005500:Follow-Up Studies D006801:Humans D008175:Lung Neoplasms D008198:Lymph Nodes D008297:Male D008654:Mesothelioma D000086002:Mesothelioma, Malignant D008875:Middle Aged D009364:Neoplasm Recurrence, Local D016273:Occupational Exposure D010997:Pleural Neoplasms D049268:Positron-Emission Tomography D020545:Respiratory Mucosa D012189:Retrospective Studies D014057:Tomography, X-Ray Computed
18F-FDG PET/CT Pleural mesothelioma CECT Asbestos fibers